Riskpilot← Back to searchSign inGet full accessANKERLØKKA LEGESENTER AS
ASActiveOrg 928446859Kråkerøyveien 11, 1671 KråkerøyGeneral medical practice activities · NACE 8621Est. 20227 employees
Revenue 2025
NOK 4,7M
+22% vs 2024
EBITDA margin
9.0%
+620% vs 2024
Equity ratio
-13.0%
Financial strength
Net profit 2025
NOK 311K
+474% vs 2024
| Revenue | NOK 4,7M | +22% |
| EBITDA | NOK 424K | +620% |
| Net profit | NOK 311K | +474% |
| Total assets | NOK 380K | +1% |
| Equity | NOK -49K | +86% |
| Employees | 7 | — |
Legal name
ANKERLØKKA LEGESENTER AS
Org number
928446859
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
3. januar 2022
Share capital
NOK 30 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drive legesentervirksomhet og alt som ellers faller naturlig inn under dette.
Address
Kråkerøyveien 11, 1671 Kråkerøy
Phone
+4769339620
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 3 101 | 3 104 | 3 878 | 4 722 |
| Staff expenses | −0 | −1 212 | −1 569 | −1 816 | −1 924 |
| EBITDA | 0 | 132 | −510 | −81 | 424 |
| Depreciation & amort. | −0 | −5 | −13 | −27 | −27 |
| EBIT | 0 | 127 | −523 | −109 | 397 |
| Net financials | 0 | −0 | 3 | 2 | 2 |
| Profit before tax | 0 | 127 | −520 | −106 | 398 |
| Tax | −0 | 28 | −114 | −23 | 88 |
| Net profit | 0 | 99 | −406 | −83 | 311 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 30 | 538 | 493 | 378 | 380 |
| Equity | 30 | 129 | −277 | −360 | −49 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 409 | 770 | 738 | 429 |
| Total debt | 0 | 409 | 770 | 738 | 429 |
EBITDA margin
9.0%
This company
15.8%
Market median
-43% vs market
20212025
Equity ratio
-13.0%
This company
38.2%
Market median
-134% vs market
20212025
Return on equity
31072100.0%
This company
18.4%
Market median
+168870009% vs market
20212025
Net profit margin
6.6%
This company
8.1%
Market median
-19% vs market
20212025
Asset turnover
12.42×
This company
1.12×
Market median
+1009% vs market
20212025
Debt / equity
8.71×
This company
0.62×
Market median
-1305% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-11-26 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MK Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25% | 25% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kase-Berg As
ANKERLØKKA LEGESENTER AS Board members of ANKERLØKKA LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Kase-Berg | Chief Executive Officer | 0 companies |
| Anne Kvale Joki | Board of Directors | 0 companies |
| Stein Jarle Pedersen | Board of Directors | 0 companies |
| Anne-Marte Toft Nordrum | Chairman | 0 companies |